包柔氏螺旋體菌IgG Elisa試劑盒-Borrelien IgG ELISA Kit代理/參數/廠家-ELISA試劑盒-艾美捷科技有限公司

PRODUCT CENTER

ELISA試劑盒

產品中心

當前位置：首頁 > 產品中心 > 免疫學產品 > ELISA試劑盒

中文名稱: 包柔氏螺旋體菌IgG Elisa試劑盒

英文名字: Borrelien IgG ELISA Kit

供應商: Biomedica Immunoassays

產品貨號: BI-21032

產品報價: ￥12x8tests

產品說明書: 點擊查看

購買方式: 90%產品中國有現貨庫存。銀行轉賬、電匯、支票、現金，在線支付寶及網銀支付，或直接與我們電話聯系400-6800-868

產品新聞

背景資料: Lyme borreliosis is a bacterial infection caused by the spirochete Borrelia Burgdorferi, Borrelia Afzelii and Borrelia Garinii and is the most vector-transmitted human disease in Europe. The spirochetal bacteria were first described and isolated in 1981 by Willi Burgdorfer in the tick Ixodes dammini in Montana (USA). The infection with Borrelia is characterized by a variety of clinical symptoms and can be divided into 3 stages:

Stage 1, early dermatitis, appearing days or weeks after the infection. Clinical: erythema migrans.
Stage 2, early disseminated infection, appears weeks to months after infection. Clinical: lymphocytic meningoradiculitis (Bannwarth's syndrome), neuroborreliosis.
Stage 3, late disseminated infection, occurring up to years after infection. Clinical: chronic progressive encephalomyelitis, acrodermatitis chronica atrophicans (ACA), chronic arthritis.
Antibiotic therapy is indicated in all stages of the disease. It shortens disease duration significantly, when instituted in stage 1. Diagnosis of the bacterial infection relies on the detection of specific IgG antibodies against Borrelia.

To ensure diagnostic specificity, the Borrelia IgG ELISA microwell strips are coated with the following Borellia-specific recombinant antigens:

p18: B. afzelii (pKo)
p21 = OspC (outer surface protein C): B. burgdorferi s.s. (B31), B. garinii (20047)
p100: B. afzelii (pKo)
VlsE: fusion protein of different genospecies
Many features of later infection are not specific to Lyme Borreliosis and occur in other conditions. The diagnosis of Lyme Borreliosis should be made only after careful evaluation of the patient′s clinical history, physical findings, laboratory evidence and exposure risk evaluation

產品描述: Method Indirect ELISA, HRP/TMB, 12×8-well detachable strips Sample type Serum, plasma and CSF Sample volume 10 μl / sample (serum and plasma), 100 μl / sample (CSF) Assay time 1 h / 30 min / 15 min Standard range 0 – 30 BBU/ml (Biomedica Borrelia Units) Sensitivity 100% (serum) 87.5% (CSF) Specificity Endogenous and recombinant human anti-Borrelia IgG (B. burgdoreri ss, B. afzelii, B. garnii, B. bavariensis)

產品特點

保存建議: +4°C

其他: Biomedica Immunoassay(bmgrp)公司成立于1988年, 總部位于奧地利維也納，主要致力于研究、開發和生產基于ELISA方法用于臨床前研究相關標記物檢測的工具。迄今為止Biomedica Immunoassay公司在心血管檢測及骨代謝檢測領域開發了一系列特色ELISA檢測試劑盒，Biomedica Immunoassay的生產過程符合GMP/GLP指南，并符合ISO 9001:2015管理體系，有CE認證。Biomedica Immunoassay的產品根據FDA， EMEA和ICH指南進行驗證，并具有驗證報告。